Easywell Biomedicals, Inc.

TPEX:1799 Rapporto sulle azioni

Cap. di mercato: NT$8.9b

Easywell Biomedicals Gestione

Gestione criteri di controllo 0/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

James Aiping Lee

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEOno data
Proprietà del CEO3.4%
Durata media del managementNessun dato
Durata media del Consiglio di amministrazioneNessun dato

Aggiornamenti recenti sulla gestione

Recent updates

What Type Of Returns Would Easywell Biomedicals'(GTSM:1799) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Feb 12
What Type Of Returns Would Easywell Biomedicals'(GTSM:1799) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

AMMINISTRATORE DELEGATO

James Aiping Lee

no data

Mandato

Mr. James Aiping Lee, Ph D, is President of Easywell Biomedicals, Inc and serves as its Manager. He has extensive experience in both medical device and pharmaceutical industries.As the founder of Magnific...